App-Quantinova.ai

Single-cell rna sequencing reveals cardiac cell-specific transcriptomic changes in dilated cardiomyopathy

Oisín Cappa - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

N/A

Induced pluripotent stem cell-derived endothelial cells from human diabetic donors carry an imprint of the diabetic milieu

Magdalini Eleftheriadou - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Primary mitral regurgitation successfully treated by percutaneous mitral valve leaflet repair results in positive cardiac reverse remodelling and functional improvement

Thomas Craven - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Mitral valve regurgitation

N/A

A 5 year study of infective endocarditis managed by a multidisciplinary team in a regional cardiothoracic centre: trends in referral, infective organisms and outcomes

Rhys Wenlock - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Infective endocarditis

N/A

Clinical outcomes up to 10 years of asymptomatic incidental aortic dissections and large aortic aneurysms detected on computer tomography (CTA) prior to transcatheter aortic valve implantation (TAVI)

Joon Tan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Clinical informatics to direct community echocardiography: an electronic healthcare record pilot

Kamatamu Amanda Mbonye - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Time to TAVI: streamlining the outpatient pathway to treatment

Sarah Fellows - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Biventricular assessment and quantification of primary mitral regurgitation is feasible and reproducible during continous supine exercise cardiovascular magnetic resonance

Thomas Craven - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Mitral valve regurgitation

N/A

Emphasizing exercise in achd: why aren’t we talking about it?

Sophie Thompson - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

The impact of the COVID-19 pandemic on transcatheter aortic valve implantation (TAVI) services in the United Kingdom: a tertiary centre experience

Joon Tan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Prevalence of aortic root dilatation in patients with fabry disease: a single centre experience

Christina Peter - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular hypertrophy

alpha-galactosidase A

Prospective longitudinal characterization of the relationship between diabetes and cardiac structural and functional changes

Amrit Chowdhary - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

The course of mitral regurgitation detected after acute myocardial infarction

Harish Sharma - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Long term follow-up and outcomes after valve replacement – a 10-year, single-centre experience of the heart valve surveillance clinic

Polyvios Demetriades - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Paravalvular regurgitation

N/A

Pre-pregnancy counselling in cardiovascular disease: a service evaluation at the leeds teaching hospitals NHS trust (LTHT) 2014–2020

Kate Hamilton - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Feasibility assessment for the implementation of a virtual hypertrophic cardiomyopathy follow up clinic in a district general hospital

Elton Luo - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Primary and secondary ICD implantation in adult congenital heart disease patients from 2006 to 2020: a single centre experience

Sally Hickman - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Advance care planning in patients with systemic right ventricular failure

Alice Copley - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Right ventricular failure

N/A

The prognostic role of epicardial adipose tissue in aortic stenosis: insights from a cardiovascular magnetic resonance study

Madeline White - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

Inherited cardiomyopathy conditions clinic in district general hospital improves esc guidelines implementation and management of patients with hypertrophic cardiomyopathy

Elton Luo - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Filters

45280 Abstracts